Detalles de la búsqueda
1.
Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.
J Virol
; 84(16): 8141-52, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20534857
2.
Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.
J Virol
; 82(1): 254-67, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17959665
3.
Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.
J Virol
; 82(6): 2975-88, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18184713
4.
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer.
Curr Gene Ther
; 8(2): 97-120, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18393831
5.
MVA and NYVAC as vaccines against emergent infectious diseases and cancer.
Curr Gene Ther
; 11(3): 189-217, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21453284
6.
Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression.
Vaccine
; 29(7): 1504-13, 2011 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21182993
7.
T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations.
PLoS One
; 6(2): e17185, 2011 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21364754
8.
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Vaccine
; 29(46): 8309-16, 2011 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21907749
9.
Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
Vaccine
; 27(24): 3165-74, 2009 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-19446187
Resultados
1 -
9
de 9
1
Próxima >
>>